3.3.5. Barriers to deprescribing
Only one of the four studies, a conference abstract, included some qualitative components in reporting midtrial data. (28) Key barriers identified from limited clinical data included low levels of clinician motivation and confidence surrounding how to manage pain with non-pharmacological techniques, and fear of dealing with aggressive patients, in particular since the changing of the National Institute for Health and Care Excellence (NICE) guidelines. (33)